Boehringer Ingelheim hosts forum in Cairo to improve cardio-renal-metabolic care
Updated 10/20/2024 12:57:00 PM
Arab Finance: Boehringer Ingelheim, a leading research-driven biopharmaceutical company, hosted a dedicated event on October 11th and 12th at the Dusit Thani LakeView in Cairo to enhance outcomes for patients living with cardiovascular, renal, and metabolic (CRM) diseases, according to an emailed press release.
More than 300 endocrinologists, nephrologists, cardiologists and primary care physicians from the Middle East and Africa participated in the two-day event.
This edition of the event combined two meetings, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting.
“Forums like the ‘CRM Summit’ and ‘MEDEX CRM’ play an important role in raising awareness of the importance of early detection and intervention in chronic kidney disease and interconnected conditions,” Merlin Thomas, Clinician Scientist and Program Leader in the Department of Diabetes at Monash University, said.
“It is crucial to keep highlighting the importance of monitoring kidney health for patients at risk. Two essential tests for this purpose should be considered – the urine albumin-creatinine ratio (uACR) test and the estimated glomerular filtration rate (eGFR) blood test,” Thomas added.
Related News
